Chipotle, Facebook Rally On Upside Earnings Surprise
at Investor's Business Daily - Fri Jul 25, 5:36PM CDT
Several leading stocks enjoyed solid, earnings-powered breakouts last week. The IBD 50 outperformed the overall market with a 3.2% gain, thanks to some outsized performances by some big names. Chipotle Mexican Grill (CMG) gapped up and soared 12%...
Celgene Beats Q2 Earnings Estimates on Strong Revlimid Sales - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 2:45PM CDT
Celgene (CELG) reported higher than expected earnings on strong revenues.
AbbVie Q2 Earnings Top on Humira Sales, Shire In Focus - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 10:52AM CDT
AbbVie (ABBV) will provide additional details on the upcoming Shire acquisition this fall.
Exelixis (EXEL) Jumps: Stock Adds 11.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 8:39AM CDT
Exelixis, Inc. (EXEL) was a big mover last session, as its shares rose over 11% on the day.
Celsion (CLSN) in Focus: Stock Adds 5.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:51AM CDT
Celsion Corp. (CLSN) was a big mover last session, as its shares rose over 5% on the day.
Agenus Inc. (AGEN) Looks Strong as Stock Surges 11.15% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 7:44AM CDT
Agenus Inc. (AGEN) was a big mover last session, as the company saw its shares shoot up over 11% on the day.
Nasdaq stocks posting largest percentage increases
AP - Thu Jul 24, 5:23PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 4:40PM CDT
UCB SA (UCBJF) announced positive top-line results from a phase III study on epilepsy candidate, brivaracetam.
Celgene, Alexion Beat Estimates, But Biotechs Fall
at Investor's Business Daily - Thu Jul 24, 4:07PM CDT
Big-cap biotechs Celgene and Alexion Pharmaceuticals modestly beat Q2 estimates and raised their guidance early Thursday, but their shares tumbled as Wall Street seemed to turn against the sector. Celgene's (CELG) Q2 earnings rose 18% over the...
Royal Caribbean and Facebook are big market movers
AP - Thu Jul 24, 3:29PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
Alexion Pharmaceuticals Q2 Earnings In Line; Revises View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 2:45PM CDT
Alexion (ALXN) reported in line earnings in the second quarter.
Actelion Beats on Q2 Earnings and Sales, Revises View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 1:50PM CDT
Actelion LTD. (ALIOF) reported second-quarter earnings of $2.83 per American Depository Receipt (ADR), up 203.77% from the prior-year earnings of 93 cents per ADR, beating the Zacks Consensus Estimate of $1.37 per share.
Why Biogen Idec Stock Is Firing on All Cylinders
Cory Renauer, The Motley Fool - Motley Fool - Thu Jul 24, 1:00PM CDT
Biogen Idec 's latest earnings report is the envy of the industry as Tecfidera keeps marching toward its multi-billion dollar potential. Beyond multiple sclerosis collaboration revenue from Roche 's best-selling cancer therapy Rituxan continues to...
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 11:00AM CDT
Illumina (ILMN) reported adjusted earnings of 57 cents per share in the second quarter of 2014, beating the Zacks Consensus Estimate by 6 cents or 11.8%
Video: Celgene, Alexion Earnings Top, But Stocks Fall
at Investor's Business Daily - Thu Jul 24, 10:39AM CDT
Big-cap biotechs Celgene (CELG) and Alexion Pharmaceuticals (ALXN) both modestly beat Q2 estimates and raised their guidance Thursday morning, but their shares were falling in the stock market today as Wall Street seemed to hope for more. Celgene's...
Stock Market News for July 24, 2014 - Market News
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 9:10AM CDT
Benchmarks finished mostly higher on Wednesday following upbeat quarterly results from healthcare and technology companies
Gilead Crushes Q2 Earnings Estimates as Sovaldi Sales Soar - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:50AM CDT
Gilead (GILD) blew away estimates on strong Sovaldi sales.
The Zacks Analyst Blog Highlights: Biogen Idec, Roche Holding, AbbVie, AmSurg and Acadia Healthcare
PR Newswire - Thu Jul 24, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Biogen Idec Inc. (Nasdaq:BIIB-Free Report), Roche Holding AG (OTC:RHHBY-Free Report), AbbVie Inc. (NYSE:ABBV-Free Report), AmSurg Corp. (Nasdaq:AMSG-Free Report) and Acadia Healthcare Company, Inc. (Nasdaq:ACHC-Free Report).
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday